The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease
Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines
Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have designed a new strategy to potentiate immunotherapy, the treatment that has revolutionized cancer management
El estudio del CNIC ha identificado un mecanismo por el que las células muertas del tumor frenan la respuesta del sistema inmunitario, reduciendo así la capacidad antitumoral de las células inmunitarias que atacan al cáncer
